Monday, August 11, 2014

Fwd: CMS Updates to Coverage Pages



---------- Forwarded message ----------
From: Centers for Medicare & Medicaid Services <cmslists@subscriptions.cms.hhs.gov>
Date: Mon, Aug 11, 2014 at 1:47 PM
Subject: CMS Updates to Coverage Pages
To: iammejtm@gmail.com


Centers for Medicare & Medicaid Services
 

CMS initiates "Screening for Colorectal Cancer - Stool DNA Testing" National Coverage Analysis for screening for colorectal cancer using CologuardTM - a multitarget stool DNA test, and posts the related Proposed Decision Memorandum, http://www.cms.gov/medicare-coverage-database/details/nca-proposed-decision-memo.aspx?NCAId=277.

Please visit the NCA tracking sheet to submit comments, http://www.cms.gov/medicare-coverage-database/details/nca-tracking-sheet.aspx?NCAId=277.  The 30-day public comment period on the proposed decision begins with this posting date, and ends after 30 calendar days. CMS considers all public comments and is particularly interested in comments that include clinical studies and other scientific evidence.

Instructions on submitting public comments can be found at http://www.cms.gov/Medicare/Coverage/InfoExchange/publiccomments.htmlWe strongly urge that all public comments be submitted through this website. Please do not submit personal health information in public comments. Comments with personal health information may not be posted to the website.

 

Background:

Medicare covers certain colorectal cancer screening tests and procedures for Medicare beneficiaries that meet certain eligibility criteria, as authorized by Sections 1861(s)(2)(R) and 1861(pp) of the Social Security Act and regulations at 42 CFR 410.37. Under 42 CFR 410.37(a)(2), CMS is allowed to include coverage of other colorectal cancer screening tests as determined by the Secretary through a national coverage determination.

Exact Sciences Corporation is participating in the FDA - CMS Parallel Review Pilot Program. CMS received a formal request for a national coverage determination from Exact Sciences Corporation, to consider coverage of CologuardTM - a multitarget sDNA colorectal cancer screening test.

 

 

Centers for Medicare & Medicaid Services (CMS) has sent this update. To contact Centers for Medicare & Medicaid Services (CMS) go to our contact us page.

 


You're getting this message because you subscribed to get email updates from the Centers for Medicare & Medicaid Services (CMS).

Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com.

This service is provided to you at no charge by Centers for Medicare & Medicaid Services (CMS).


This e-mail was sent to iammejtm@gmail.com using GovDelivery, on behalf of the Centers for Medicare & Medicaid Services (410-786-5473) · 7500 Security Boulevard · Baltimore MD 21244



--
Jeremy Tobias Matthews

No comments:

Post a Comment